An interview with FDA commissioner Hayes.
D003257:Consumer Product Safety; D003362:Cost-Benefit Analysis; D004340:Drug Contamination / Q000517:prevention & control; D004348:Drug Labeling / Q000191:economics / Q000592:standards; D004992:Ethics, Medical; D006266:Health Education / Q000592:standards; D006973:Hypertension / Q000209:etiology / Q000517:prevention & control / Q000628:therapy; D007880:Legislation, Drug / Q000639:trends*; D010604:Pharmacy; D012957:Societies, Pharmaceutical; D012964:Sodium / Q000009:adverse effects; D014481:United States; D014486:United States Food and Drug Administration
D012964:Sodium